SCHEMBL9813544

SCHEMBL9813544

CN1C(=O)CSC1=CC(=O)Nc1cccc(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ MEN1 O00255 5/20 0.51
▸ KMT2A Q03164 5/20 0.51
▸ MAPT P10636 3/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ PSMD14 O00487 1/20 0.47
▸ GRM5 P41594 3/20 0.46
▸ HTT P42858 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ MMP1 P03956 3/20 0.44
▸ MMP2 P08253 3/20 0.44
▸ MMP9 P14780 3/20 0.44
▸ MAOB P27338 3/20 0.44
▸ MAOA P21397 2/20 0.44
▸ EGFR P00533 1/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ USP2 O75604 1/20 0.43
▸ TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9813543 1.00 ALDH1A1 (0.56) ALDH1A1TDP1MEN1KMT2AMAPT
SCHEMBL9813604 0.85 ALDH1A1 (0.57) ALDH1A1TDP1MEN1KMT2AMAPT
SCHEMBL9813602 0.85 ALDH1A1 (0.57) ALDH1A1TDP1MEN1KMT2AMAPT
SCHEMBL9813589 0.85 ALDH1A1 (0.66) ALDH1A1TDP1MEN1KMT2AMAPT
SCHEMBL9813586 0.85 ALDH1A1 (0.66) ALDH1A1TDP1MEN1KMT2AMAPT
SCHEMBL9813551 0.81 ALDH1A1 (0.59) ALDH1A1TDP1MEN1KMT2AMAPT
SCHEMBL9813552 0.81 ALDH1A1 (0.59) ALDH1A1TDP1MEN1KMT2AMAPT
SCHEMBL9813546 0.78 ALDH1A1 (0.71) ALDH1A1TDP1MAPTPSMD14MMP1
SCHEMBL9813545 0.78 ALDH1A1 (0.71) ALDH1A1TDP1MAPTPSMD14MMP1
Ralitoline SCHEMBL635346 0.78 PSMD14 (0.55) ALDH1A1TDP1PSMD14MAOBEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0124911-B1 4-OXO-THIAZOLIDIN-2-YLIDEN-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM ILLNESSES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-07-31 — — EP disclosed
US-4563471-A CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1986-01-07 — — US disclosed
EP-0124911-A2 4-Oxo-thiazolidin-2-yliden-acetamide derivatives, process for their preparation, and medicaments for the treatment of central nervous system illnesses containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1984-11-14 — — EP disclosed
Send feedback